What research findings does Orexin A have regarding wakefulness, alertness, and sleep regulation?
Increased wakefulness and spontaneous activity suggest the regulation of arousal. Another study reports: some REM sleep stability and distribution attention error indicators improved.[1] ↗ [2] ↗
Currently, 3 original studies related to the theme of this page have been selected. The number of studies includes different designs, populations, or preparations, not commercial clinical efficacy ratings. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.
Comparison of study design and results
Results from different populations, species, materials, or follow-up times cannot be directly combined. The table below is a comparative summary of published data, not new experimental data.
| Literature | Study subjects and design | Observation and discovery | Scope of Explanation |
|---|---|---|---|
| 2015 · PMID 25845696 | Male rats; Orexin-A brain region microinjection study | Increased wakefulness and spontaneous activity suggest the regulation of arousal. | Special intracerebral delivery, cannot apply data from regular peripheral or nasal products. |
| 2014 · PMID 24406723 | 14 narcolepsy patients with cataplexy; randomized double-blind intranasal crossover trial | Partial REM sleep stability and distribution attention error indicators improved. | Small-sample acute experiment; cannot claim confirmed sustained awake efficacy, research nasal formulation differs from catalog products. |
| 1999 · PMID 10485925 | Rats; Electrophysiology and arousal behavior in brain regions | Orexin-A increases the activity of locus coeruleus neurons and wakefulness, providing a basis for the sleep-wake mechanism. | 1999 Animal basic research, not human clinical administration evidence. |
References
What wake-up mechanisms does microinjection research in the brain region illustrate?
Increased wakefulness and spontaneous activity suggest the regulation of arousal.[1] ↗
Male rats; Orexin-A brain region microinjection study
Special intracerebral delivery, cannot apply data from regular peripheral or nasal products.
View the Article Title and Full Citation＋
Promotion of Wakefulness and Energy Expenditure by Orexin-A in the Ventrolateral Preoptic Area.
Sleep · Volume Issue Year 2015
First published on 2015-09-01 · PMID 25845696
DOI 10.5665/sleep.4970
What findings were observed regarding sleep and attention with intranasal Orexin-A?
Partial REM sleep stability and distribution attention error indicators improved.[2] ↗
14 narcolepsy patients with cataplexy; randomized double-blind intranasal crossover trial
Small-sample acute experiment; cannot claim confirmed sustained awake efficacy, research nasal formulation differs from catalog products.
View the Article Title and Full Citation＋
The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
Behavioural Brain Research · Volume/Issue Year 2014
First published on 2014-01-07 · PMID 24406723
DOI 10.1016/j.bbr.2013.12.045
What does research on neuronal activity and arousal in spots coeruleus indicate?
Orexin-A increases the activity of locus coeruleus neurons and wakefulness, providing a basis for the sleep-wake mechanism.[3] ↗
Rats; Electrophysiology and arousal behavior in brain regions
1999 Animal basic research, not human clinical administration evidence.
View the Article Title and Full Citation＋
Orexin A activates locus coeruleus cell firing and increases arousal in the rat.
Proceedings of the National Academy of Sciences of the United States of America · Volume and Issue Year 1999
First published 1999-09-14 · PMID 10485925
DOI 10.1073/pnas.96.19.10911
Common issues and corresponding evidence
What research findings does Orexin A have regarding wakefulness, alertness, and sleep regulation?＋
Increased wakefulness and spontaneous activity suggest the regulation of arousal. Another study reports: some REM sleep stability and distribution attention error indicators improved.[1] ↗ [2] ↗
Has nasal research on Orexin-A demonstrated the ability to maintain long-term wakefulness?＋
None. The 14-person short-term crossover trial on this page mainly reports REM stability and some attention indicators; microinjection results in animal brains cannot be directly applied to regular dosing.[2] ↗ [1] ↗
Orexin A—these conclusions apply to which study populations?＋
Male rats; Orexin-A brain region microinjection study; 14 patients with cataplexy-type narcolepsy; randomized double-blind nasal crossover trial; rats; brain region electrophysiology and wakefulness behavior. Special intracerebral delivery, cannot be applied to ordinary peripheral or nasal products.[1] ↗ [2] ↗ [3] ↗
Orexin A
Return to catalog specifications and batch file verification entry.
